RA
NVAX icon

Royce & Associates’s Novavax NVAX Stock Holding History

Royce & Associates’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,500
Closed -$819K – 1244
2018
Q1 		$819K Sell
19,500
-8,000
-29% -$321K 0.01% 1002
2017
Q4 		$682K Hold
27,500
– – ﹤0.01% 1021
2017
Q3 		$627K Hold
27,500
– – ﹤0.01% 1015
2017
Q2 		$633K Hold
27,500
– – ﹤0.01% 1027
2017
Q1 		$704K Hold
27,500
– – ﹤0.01% 1019
2016
Q4 		$693K Sell
27,500
-17,500
-39% -$510K ﹤0.01% 981
2016
Q3 		$1.87M Buy
+45,000
New +$5.81M 0.01% 823

Other funds holding NVAX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return